Can metabotyping help deliver the promise of personalised nutrition?

Proceedings of the Nutrition Society

Volumn 75, Issue 1, 2016, Pages 106-114

  O'Donovan, Clare B ^a   Walsh, Marianne C ^a   Gibney, Michael J ^a   Gibney, Eileen R ^a   Brennan, Lorraine ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Cluster analysis; Metabotyping; Personalised nutrition; Targeted nutrition

Indexed keywords

APOLIPOPROTEIN A2; APOLIPOPROTEIN E; C REACTIVE PROTEIN; CYTOCHROME P450 1A2; DIPEPTIDYL CARBOXYPEPTIDASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ADULT; ALZHEIMER DISEASE; ATTITUDE TO HEALTH; BEHAVIOR CHANGE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; CONFERENCE PAPER; CONTROLLED STUDY; DIETARY COMPLIANCE; DIETARY INTAKE; EUROPE; FAT INTAKE; GENOTYPE; HEALTH BEHAVIOR; HEALTH PROGRAM; HUMAN; HYPERTENSION; INTENTION TO TREAT ANALYSIS; INTERNET; INTERVENTION STUDY; LIFESTYLE; LIPID METABOLISM; METABOLIC SYNDROME X; METABOTYPING; OBESITY; ONLINE ANALYSIS; PARKINSON DISEASE; PERSONAL DIGITAL ASSISTANT; PERSONALIZED MEDICINE; PERSONALIZED NUTRITION; PHENOTYPE; PHYSICAL ACTIVITY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF MONITORING; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 84959471967     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665115002347     Document Type: Conference Paper

References (60)

1. Williams RJ (1950) Concept of genetotrophic disease. Nutr Rev 8, 257-260.
2. Bickel H, Gerrard J & Hickmans EM (1953) Influence of phenylalanine intake on phenylketonuria. Lancet 265, 812-813.
3. Utermann G, HeesM & Steinmetz A (1977) Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature 269, 604-607.
4. Minihane AM, Khan S, Leigh-Firbank EC et al. (2000) ApoE polymorphism and fish oil supplementation in subjects with an atherogenic lipoprotein phenotype. Arterioscler Thromb Vasc Biol 20, 1990-1997.
5. Department of Health (1991) Dietary Reference Values for Food Energy and Nutrients for the United Kingdom: Report of the Panel on Dietary Reference Values of the Committee on Medical Aspects of Food Policy. London: the Stationary Office.
6. Venter JC, Adams MD, Myers EW et al. (2001) The sequence of the human genome. Science 291, 1304-1351.
7. Lander ES, Linton LM, Birren B et al. (2001) Initial sequencing and analysis of the human genome. Nature 409, 860-921.
8. Ronteltap A, van Trijp H, Berezowska A et al. (2013) Nutrigenomics-based personalised nutritional advice: in search of a business model? Genes Nutr 8, 153-163.
9. Gibney MJ & Walsh MC (2013) The future direction of personalised nutrition: my diet, my phenotype, my genes. Proc Nutr Soc 72, 219-225.
10. Hamburg MA & Collins FS (2010) The path to personalized medicine. N Engl J Med 363, 301-304.
11. Celis-Morales C, Lara J & Mathers JC (2014) Personalising nutritional guidance for more effective behaviour change. Proc Nutr Soc 12, 1-9.
12. Kroeze W, Oenema A, Dagnelie PC et al. (2008) Examining the minimal required elements of a computertailored intervention aimed at dietary fat reduction: results of a randomized controlled dismantling study. Health Educ Res 23, 880-891.
13. Alexander GL, McClure JB, Calvi JH et al. (2010) A randomized clinical trial evaluating online interventions to improve fruit and vegetable consumption. Am J Public Health 100, 319-326.
14. Wright JL, Sherriff JL, Dhaliwal SS et al. (2011) Tailored, iterative, printed dietary feedback is as effective as group education in improving dietary behaviours: results from a randomised control trial in middle-aged adults with cardiovascular risk factors. Int J Behav Nutr Phys Act 8 43.
15. Hutchesson MJ, Collins CE, Morgan PJ et al. (2014) Changes to dietary intake during a 12-week commercial web-based weight loss program: a randomized controlled trial. Eur J Clin Nutr 68, 64-70.
16. Ambeba EJ, Ye L, Sereika SM et al. (2015) The use of mHealth to deliver tailored messages reduces reported energy and fat intake. J Cardiovasc Nurs 30, 35-43.
17. Springvloet L, Lechner L, de Vries H et al. (2015) Shortand medium-term efficacy of a Web-based computertailored nutrition education intervention for adults incluDing cognitive and environmental feedback: randomized controlled trial. J Med Internet Res 17, e23.
18. Tate DF, Jackvony EH & Wing RR (2006) A randomized trial comparing human e-mail counseling, computerautomated tailored counseling, and no counseling in an internet weight loss program. Arch Intern Med 166, 1620-1625.
19. Hunter CM, Peterson AL, Alvarez LMet al. (2008) Weight management using the internet a randomized controlled trial. Am J Prev Med 34, 119-126.
20. Bennett GG, Herring SJ, Puleo E et al. (2010) Web-based weight loss in primary care: a randomized controlled trial. Obesity 18, 308-313.
21. Kraschnewski JL, Stuckey HL, Rovniak LS et al. (2011) Efficacy of a weight-loss website based on positive deviance. A randomized trial. Am J Prev Med 41, 610-614.
22. Burke LE, Styn MA, Sereika SM et al. (2012) Using mHealth technology to enhance self-monitoring for weight loss: a randomized trial. Am J Prev Med 43, 20-26.
23. Collins CE, Morgan PJ, Jones P et al. (2012) A 12-week commercial web-based weight-loss program for overweight and obese adults: randomized controlled trial comparing basic versus enhanced features. J Med Internet Res 14, e57.
24. Chambliss HO, Huber RC, Finley CE et al. (2011) Computerized self-monitoring and technology-assisted feedback for weight loss with and without an enhanced behavioral component. Patient Educ Couns 85, 375-382.
25. Morgan PJ, Callister R, Collins CE et al. (2013) The SHEDIT community trial: a randomized controlled trial of internet-and paper-based weight loss programs tailored for overweight and obese men. Ann Behav Med 45, 139-152.
26. Sternfeld B, Block C, Quesenberry CP et al. (2009) Improving diet and physical activity with ALIVE: a worksite randomized trial. Am J Prev Med 36, 475-483.
27. Winett RA, Anderson ES, Wojcik JR et al. (2011) Guide to health: a randomized controlled trial of the effects of a completely WEB-based intervention on physical activity, fruit and vegetable consumption, and body weight. Transl Behav Med 1, 165-174.
28. Broekhuizen K, van Poppel MN, Koppes LL et al. (2012) Can multiple lifestyle behaviours be improved in people with familial hypercholesterolemia? Results of a parallel randomised controlled trial. PLoS ONE 7, e50032.
29. Mouttapa M, Robertson TP, McEligot AJ et al. (2011) The personal nutrition planner: a 5-week, computer-tailored intervention for women. J Nutr Educ Behav 43, 165-172.
30. Jacobs N, Clays E, De Bacquer D et al. (2011) Effect of a tailored behavior change program on a composite lifestyle change score: a randomized controlled trial. Health Educ Res 26, 886-895.
31. Arkadianos I, Valdes AM, Marinos E et al. (2007) Improved weight management using genetic information to personalize a calorie controlled diet. Nutr J 6, 29.
32. Chao S, Roberts JS, Marteau TM et al. (2008) Health behavior changes after genetic risk assessment for Alzheimer disease: the REVEAL study. Alzheimer Dis Assoc Disord 22, 94-97.
33. Bloss CS, Schork NJ & Topol EJ (2011) Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med 364, 524-534.
34. Bloss CS, Wineinger NE, Darst BF et al. (2013) Impact of direct-to-consumer genomic testing at long term follow-up. J Med Genet 50, 393-400.
35. Grant RW, O'Brien KE, Waxler JL et al. (2013) Personalized genetic risk counseling to motivate diabetes prevention: a randomized trial. Diabetes Care 36, 13-19.
36. Nielsen DE & El-Sohemy A (2014) Disclosure of genetic information and change in dietary intake: a randomized controlled trial. PLoS ONE 9, e112665.
37. Frankwich KA, Egnatios J, Kenyon ML et al. (2015) Differences in weight loss between persons on standard balanced vs nutrigenetic diets in a randomized controlled trial. Clin Gastroenterol Hepatol, Epublication ahead of print version.
38. Vernarelli JA, Roberts JS, Hiraki S et al. (2010) Effect of Alzheimer disease genetic risk disclosure on dietary supplement use. Am J Clin Nutr 91, 1402-1407.
39. Marteau TM, French DP, Griffin SJ et al. (2010) Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev. 10, Cd007275.
40. Celis-Morales C, LivingstoneKM, Marsaux CF et al. (2015) Design and baseline characteristics of the Food4Me study: a web-based randomised controlled trial of personalised nutrition in seven European countries. Genes Nutr 10, 450.
41. Brennan L (2008) Session 2: personalised nutrition. Metabolomic applications in nutritional research. Proc Nutr Soc 67, 404-408.
42. Kaput J (2008) Nutrigenomics research for personalized nutrition and medicine. Curr Opin Biotechnol 19, 110-120.
43. Nicholson JK, Holmes E, Kinross JM (2012) Metabolic phenotyping in clinical and surgical environments. Nature 491, 384-92.
44. Morris C, O'Grada C, Ryan M et al. (2013) Identification of differential responses to an oral glucose tolerance test in healthy adults. PLoS ONE 8, e72890.
45. Holmes E, Wilson ID & Nicholson JK (2008) Metabolic phenotyping in health and disease. Cell 134, 714-717.
46. CastalDi PJ, Dy J, Ross J et al. (2014) Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax 69, 415-422.
47. Erro R, Vitale C, Amboni M et al. (2013) The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. PLoS ONE 8, e70244.
48. Moore WC, Meyers DA, Wenzel SE et al. (2010) Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 181, 315-323.
49. Lee JH, Cho MH, McDonald ML et al. (2014) Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene. Respir Med 108, 1469-1480.
50. Cho MH, Washko GR, Hoffmann TJ et al. (2010) Cluster analysis in severe emphysema subjects using phenotype and genotype data: an exploratory investigation. Respir Res 11, 30.
51. Ma LY, Chan P, Gu ZQ (2015) Heterogeneity among patients with Parkinson's disease: cluster analysis and genetic association. J Neurol Sci, Epub ahead of print.
52. Richette P, Clerson P, Perissin L et al. (2013) Revisiting comorbidities in gout: a cluster analysis. Ann Rheum Dis 74, 142-147.
53. Viniol A, Jegan N, Hirsch O et al. (2013) Chronic low back pain patient groups in primary care-A cross sectional cluster analysis. BMC Musculoskelet Disord 14, 294.
54. Penrod JD, Litke A, Hawkes WG et al. (2007) Heterogeneity in hip fracture patients: age, functional status, and comorbidity. J Am Geriatr Soc 55, 407-413.
55. Eastwood EA, Magaziner J, Wang J et al. (2002) Patients with hip fracture: subgroups and their outcomes. J Am Geriatr Soc 50, 1240-1249.
56. van Bochove K, van Schalkwijk DB, Parnell LD et al. (2012) Clustering by plasma lipoprotein profile reveals two distinct subgroups with positive lipid response to fenofibrate therapy. PLoS ONE. 7, e38072.
57. O'Sullivan A, Gibney MJ, Connor AO et al. (2011) Biochemical and metabolomic phenotyping in the identification of a vitamin D responsive metabotype for markers of the metabolic syndrome. Mol Nutr Food Res 55, 679-690.
58. O'Donovan CB, Walsh MC, Nugent AP et al. (2014) Use of metabotyping for the delivery of personalised nutrition. Mol Nutr Food Res 59, 377-385.
59. Brotons C, Drenthen AJ, Durrer D et al. (2012) Beliefs and attitudes to lifestyle, nutrition and physical activity: the views of patients in Europe. Fam Pract 29, i49-i55.
60. Brotons C, Bjorkelund C, Bulc M et al. (2005) Prevention and health promotion in clinical practice: the views of general practitioners in Europe. Prev Med 40, 595-601.